We noticed JavaScript is turned off in your browser settings. For a better viewing experience, enable JavaScript. If you're unsure of how to do this, click here to download a new browser.

FOR PREVIEW ONLY (Print)

Phillip Fleshner, MD

Director, Colorectal Surgery Research

Shierley Jesslyne and Emmeline Widjaja Chair in Colorectal Surgery

8737 Beverly Boulevard,
Suite 101
Los Angeles, CA 90048

Phone:

310-289-9224

Fax:

310-289-8995

Phillip Fleshner, MD

Director, Colorectal Surgery Research

Shierley Jesslyne and Emmeline Widjaja Chair in Colorectal Surgery

  • Surgery-Colo-Rectal
  • Surgical Oncology

Blood in Stool

Colonoscopy

Colorectal Cancer Screening (Colon, Rectal)

Colorectal Polyps (Colon, Rectal)

Hemorrhoids

Inflammatory Bowel Disease (IBD)

Polyposis

Rectal Bleeding

Sigmoidoscopy

Dr. Fleshner's main clinical and research interests are directed towards optimizing outcomes and techniques in the surgical management of Crohn's disease and ulcerative colitis. Dr. Fleshner has written numerous articles for peer-reviewed publications, including the Journal of the American College of Surgeons, Diseases of the Colon and Rectum, Gut, American Journal of Surgery and Annals of Surgery.

  • Medical School: Albert Einstein College of Medicine, New York, 1984
  • Fellowship: Massachusetts General Hospital, 1988
  • Residency: Mount Sinai Medical Center, 1990
  • Fellowship: Lahey Clinic, Boston, MA, 1991
  • Alpha Omega Alpha Honor Medical Society Award, 1984
  • Arthur H. Aufses Sr. Prize in Surgery Award, 1990
  • Harry E. Bacon Foundation Award, 1993
  • American Society of Colon and Rectal Surgeons Traveling Fellow Award, 1994
  • Golden Apple Teaching Award, Department of Surgery, Cedars-Sinai Medical Center 1994, 1995, 2002
  • Program Director, Colorectal Surgery Fellowship Program Cedars-Sinai Medical Center, 2003
  • Chair Holder, Widjaja Endowed Chair in Colorectal Surgery, 2010
  • Northwest Society of Colon and Rectal Surgeons Award at ASCRS Annual Meeting, 2013

Show moreShow less

Click here for a list of peer-reviewed publications.

  • Norman JM, Handley SA, Baldridge MT, Droit L, Liu CY, Keller BC, Kambal A, Monaco CL, Zhao G, Fleshner P, Stappenbeck TS, McGovern DPB, Keshavarzian A, Mutlu EA, Sauk J, Gevers DS, Xavier RJ, Wang D, Parkes M, Virgin HM. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 2015;60(3):447-60.
  • Zaghiyan K, McGovern D, Fleshner P. Should biologic agents be stopped before surgery for IBD? Expert Rev Gastro Hepat 2015;9(3):269-72.
  • Lau C, Dubinsky M, Melmed G, Vasiliauskas E, Berel D, McGovern D, Ippoliti A, Shih D, Targan S, Fleshner P. The impact of preoperative serum anti-TNFα therapy levels on early postoperative outcomes in inflammatory bowel disease. Ann Surg 2015;261(3):487-96.
  • Felder S, Fleshner P. Stoma construction: single-port laparoscopic approach. In: Bardakcioglu O, ed. Advanced techniques in minimally invasive and robotic colorectal surgery (Ed.) Springer US, 2015:215-219.
  • Felder SI, Murrell Z, Fleshner P. Minimally invasive approach for stoma creation in Minimally Invasive Approaches to Colon and Rectal Disease, Ross H, Lee S, Mutch M, Rivadeneira DE, Steele S. (Eds.). Springer New York; 2015:169-177.
  • Zaghiyan K, McGovern D, Fleshner P. Should biologic agents be stopped before surgery for IBD? Expert Rev Gastro Hepat 2015;9(3):269-72.

Show moreShow less

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or